Price $283.68 |
Market Cap
44.21B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
8.2
|
P/B
4.0
|
P/S
3.12
|
Dividend %
-
|
|
P/CF
82.3
|
P/FCF
7.2
|
Op. Cash Flow
7.07M
|
FCF
39.2
|
|
Op. Margin
50.90%
|
Net Margin
40.90%
|
ROE
46.30%
|
ROI
30.50%
|
|
ROA
22.30%
|
EPS Growth
27.00%
|
Current Ratio
1.7
|
Debt/Equity
33.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China SXT Pharmaceuticals Inc (SXTC) | $0.25 | - | - | 19.6M | Strong Buy |
| Champions Oncology Inc (CSBR) | $9.25 | - | - | 107.7M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.86 | - | - | 70.1M | Strong Buy |
| RadNet Inc. (RDNT) | $14.81 | - | - | 775.7M | Strong Buy |
| Community Health Systems Inc (CYH) | $4.22 | - | - | 649.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
